DMPI - 1.85 Pre-market at 2.00/2.11 DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM http://stockcharts.com/c-sc/sc?s=DMPI&p=D&b=5&g=0&i=t60643219506&r=1498135881016 http://stockcharts.com/c-sc/sc?s=DMPI&p=W&b=5&g=0&i=t74944896800&r=1498135898278